Delivery Order SPE2DB20D1004-SPE2DB25FNGTS

Award Date 5/1/25
Potential Completion Date 5/2/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,978.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4567924056 - VEVYE 0.1% EYE DROP 2ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 16, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,564.51 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567039243 ! VEVYE 0.1% EYE DROP 2ML, with a period of performance through January 27, 2025. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,338.59, is for the delivery of a pharmaceutical product called "4567557411 ! VEVYE 0.1% EYE DROP 2ML". The contract is a Firm Fixed Price Delivery Order with a period of performance through March 13, 2025. There is no set-aside designation for this award. The contract is part of a larger...
This federal contract award, valued at $1,227.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, a delivery order under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999, covers the procurement of 4566422753 VEVYE 0.1% EYE DROP 2ML, a pharmaceutical product. The IDC serves as a primary vehicle for DLA to obtain a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,135.81 firm fixed-price delivery order contract is for the supply of 4566861414 ! VEVYE 0.1% EYE DROP 2ML, with a performance period ending on January 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,758.18, is for the delivery of 4567503375 ! VEVYE 0.1% EYE DROP 2ML, a pharmaceutical product. The contract has an ultimate completion date of March 10, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,642.59 and is for the delivery of 4566825304 ! VEVYE 0.1% EYE DROP 2ML. This is a firm fixed-price delivery order contract with a completion date of January 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,047.98, is for the delivery of 4567074598 ! VEVYE 0.1% EYE DROP 2ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 29, 2025. There is no set-aside designation associated with this award....
This federal contract award, with the ID SPE2DB20D1004|SPE2DB25FNEDY, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,047.98, is for the delivery of a 0.1% eye drop medication in 2ml vials. This is a Firm Fixed Price Delivery Order contract, with a completion date of January 15, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a $1,047.98 Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for 4567829218 ! VEVYE 0.1% EYE DROP 2ML, which is a medical product used to treat eye conditions. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNGTS
    Delivery Order

This federal contract award, valued at $2,057.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order with a firm fixed price, is for the provision of a pharmaceutical product, "4568105593 ! VEVYE 0.1% EYE DROP 2ML," with a performance period ending on May 2, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract award is likely a specific delivery order against that larger IDC, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs and other government agencies. The contract is not designated as a set-aside, indicating open competition.

Generated 7/31/25, 9:49 AM